At the same time, with the promotion of healthy lifestyle behaviors, diabetes management—particularly for T1D—has long benefited significantly from technological innovation applied in clinical settings, especially with regard to glucose self-monitoring and insulin delivery. This evidence concerns the gene INS and diabetes mellitus.